Wave Life Sciences (WVE) Total Current Liabilities (2014 - 2026)

Wave Life Sciences (WVE) has 13 years of Total Current Liabilities data on file, last reported at $50.8 million in Q2 2026.

• Quarterly Total Current Liabilities fell 41.86% year-over-year to $50.8 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $50.8 million (down 41.86% YoY) and the FY2025 annual result came in at $95.1 million, down 14.32% from the prior year.
• Total Current Liabilities climbed to $50.8 million in Q2 2026, from $49.8 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $186.4 million in Q4 2023 to a low of $49.8 million in Q1 2026.
• A 5-year average of $105.3 million and a median of $91.2 million in 2025 frame the typical range for Total Current Liabilities.
• Annual changes were most pronounced in 2023 — Total Current Liabilities jumped 160.68% — and 2025, when it slumped 49.69%.
• Tracing WVE's Total Current Liabilities over 5 years: stood at $71.5 million in 2022, then surged by 160.68% to $186.4 million in 2023, then plunged by 40.49% to $111.0 million in 2024, then slipped by 14.32% to $95.1 million in 2025, then slumped by 46.55% to $50.8 million in 2026.
• The last three Total Current Liabilities figures came in at $50.8 million (Q2 2026), $49.8 million (Q1 2026), and $95.1 million (Q4 2025), per Business Quant data.